CF
FBIO icon

Carlson Financial’s Fortress Biotech FBIO Stock Holding History

Carlson Financial’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.7K Sell
12,659
-350
-3% -$903 0.02% 195
2026
Q1 		$36.3K Hold
13,009
– – 0.02% 180
2025
Q4 		$47.6K Buy
+13,009
New +$37.1K 0.03% 179

Other funds holding FBIO

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Carlson Financial's FBIO Position: Q2 2026 in Review

Carlson Financial reduced its Fortress Biotech (FBIO) stake by 2.7% in Q2 2026, selling an estimated $903 and leaving 12,659 shares worth $38.7K. The position accounts for 0.02% of the portfolio, ranked #195.

Carlson Financial first reported a position in FBIO in Q4 2025 and has held it in 3 quarters since. The position peaked at $47.6K in Q4 2025. 55 funds tracked by Wall St. Rank hold FBIO as of Q2 2026.

  • Carlson Financial held 12,659 shares of Fortress Biotech worth $38.7K as of Q2 2026.
  • Carlson Financial sold 350 Fortress Biotech shares in Q2 2026, an estimated $903.
  • Fortress Biotech made up 0.02% of Carlson Financial's portfolio in Q2 2026, its #195 holding.
  • Carlson Financial first reported a position in Fortress Biotech in Q4 2025 and has held it in 3 quarters since.
  • Carlson Financial's Fortress Biotech position peaked at $47.6K in Q4 2025.
  • 55 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2026.

Based on Carlson Financial's 13F filing for Q2 2026, filed 24 Aug 2026.